Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q1 CY2026 results , with sales up 9.2% year on year to ...

Recommendations for using noninvasive testing strategies and certain criteria when working with patients to make an accurate, definitive diagnosis of advanced fibrosis caused by nonalcoholic ...

—A team of researchers in Tokyo recently took on the challenge of attempting to determine whether comprehensive genomic profiling has clinical utility in a large cohort of patients with non-small cell ...

A wellness writer’s visit to MIORA Performance and Longevity in Colorado uncovered a significant, previously undetected hormone imbalance despite her disciplined lifestyle. Comprehensive biomarker ...

Cancer diagnosis used to be a simple, binary call: either someone had the disease or they didn’t. And patients with the same broad class of cancer tend to receive the same class of therapy. It was a ...

NGS utilization increased over time but left substantial proportions untested across metastatic breast, prostate, pancreatic, ...

"Clinicians performing tumor biopsy need to ensure that there’s adequate tissue for both diagnosis and NGS testing. Having immediate pathology review of biopsy specimens in the operating room can ...

PPG Industries, Inc. (NYSE:PPG) is one of the 10 Best Slow Growth Stocks to Buy According to Analysts. On April 20, 2026, PPG Industries, Inc. (NYSE:PPG) announced the installation of an advanced ...

Across all cancer types, less than 50% of patients underwent biomarker testing before first-line treatment. Many patients with advanced cancer do not receive guideline-recommended biomarker testing ...

Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy Herein, we highlight the strengths ...

From 7% to nearly 9% of patients with advanced cancer were found to harbor a germline variant with targeted therapeutic actionability in the first study of its kind. The study involved 11,974 patients ...

HANOI, Vietnam, Jan. 29, 2026 /PRNewswire/ --On January 28, 2026, in Hanoi, FPT Corporation officially announced the establishment of the FPT Advanced Semiconductor Testing and Packaging Plant, aiming ...